---
figid: PMC9456282__ijms-23-09954-g009
figtitle: Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NFKB
  Signaling Pathway in an Experimental NASH Model
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9456282
filename: ijms-23-09954-g009.jpg
figlink: /pmc/articles/PMC9456282/figure/ijms-23-09954-f009/
number: F9
caption: 'Schematic diagram showing how caffeine affects the NASH experimental model.
  Caffeine attenuates the experimental NASH progression possibly by modulating the
  nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear factor-κB (NF-κB)
  signaling pathways, thereby reducing oxidative stress and inflammation, respectively.
  Caffeine also attenuates fibrosis progression by modulating mitogen-activated protein
  kinases (MAPK) and transforming growth factor-beta (TGF-β) signaling pathways, thereby
  decreasing the activation of hepatic stellate cells (HSCs). Caffeine inhibits inflammasome
  activation by blocking the toll-like receptor 4 (TLR4)/MAPK/NF-κB signaling pathway.
  ROS: reactive oxygen species; DAMPs: damage-associated molecular patterns; α-SMA:
  smooth muscle alpha-actin; IL: interleukin; TNF-α: tumor necrosis factor-alpha.'
papertitle: Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB
  Signaling Pathway in an Experimental NASH Model.
reftext: Eduardo E. Vargas-Pozada, et al. Int J Mol Sci. 2022 Sep;23(17):9954.
year: '2022'
doi: 10.3390/ijms23179954
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: caffeine | non-alcoholic steatohepatitis | nucleotide-binding domain | leucine-rich-containing
  family | pyrin domain-containing-3 inflammasome | toll-like receptor 4 | mitogen-activated
  protein kinase | nuclear factor-κB
automl_pathway: 0.9256473
figid_alias: PMC9456282__F9
figtype: Figure
redirect_from: /figures/PMC9456282__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9456282__ijms-23-09954-g009.html
  '@type': Dataset
  description: 'Schematic diagram showing how caffeine affects the NASH experimental
    model. Caffeine attenuates the experimental NASH progression possibly by modulating
    the nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear factor-κB (NF-κB)
    signaling pathways, thereby reducing oxidative stress and inflammation, respectively.
    Caffeine also attenuates fibrosis progression by modulating mitogen-activated
    protein kinases (MAPK) and transforming growth factor-beta (TGF-β) signaling pathways,
    thereby decreasing the activation of hepatic stellate cells (HSCs). Caffeine inhibits
    inflammasome activation by blocking the toll-like receptor 4 (TLR4)/MAPK/NF-κB
    signaling pathway. ROS: reactive oxygen species; DAMPs: damage-associated molecular
    patterns; α-SMA: smooth muscle alpha-actin; IL: interleukin; TNF-α: tumor necrosis
    factor-alpha.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GABPA
  - NFE2L2
  - NFKB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - NLRP3
  - IL13
  - IL17A
  - TNF
  - TGFB1
  - TGFB2
  - TGFB3
  - FUT1
  - ACTA1
  - Keap1
  - cnc
  - Dif
  - dl
  - Rel
  - MKP-4
  - p38b
  - rl
  - egr
  - dpp
  - gbb
  - put
  - mav
  - Hcs
---
